Surgical Options for Benign Prostatic Hyperplasia (BPH)
نویسنده
چکیده
In 1788 John Hunter first described the pathology of prostatic hyperplasia and its effects on the upper urinary tract. It took a century for the first suprapubic prostatectomy to be carried out in 1887 by AF McGill in Leeds (though Americans tend to claim credit to Fuller in New York in 1894.) The procedure was subsequently p o p u l a r i s e d b y S i r Pe t e r F r e ye r . R e t r o p u b i c prostatectomy was first performed in 1908 but failed to attract attention until it was reintroduced by Terrence Millin in 1947. Since then, it remains the open operation of choice in UK for BPH. In 1909 H H Young introduced the transurethral cold punch resection of the prostate. M Stern introduced the first resectoscope in 1926 and shortly afterwards H Bumpus at Mayo Clinic introduced diathermy cutting and coagulation. In 1932 Joseph McCarthy introduced the fore-oblique lens, continuous irrigation and working element for resection, and performed the first series of transurethral resection of prostate (TURP) in a manner similar to what we are doing today. With further advances in technology and technique, TURP became established as the most commonly performed operation for BPH, and the open procedures are relegated only to situations where TURP are difficult or risky. This combination essentially formed the gold standard of surgery for BPH we are still adopting today. However, TURP is not without its complications. It keeps on evolving in technology under pressure for fewer complications. Other new technologies also sprang up in the last two decades utilising other forms of energy to achieve tissue destruction or removal in BPH. Many such techniques came and went. However, some stay as useful adjunct to the gold standard of TURP with open surgery back up, and appear promising as new directions for further evolution of intervention for BPH. This article orientates the reader through the myriad of contemporary procedures Hong Kong urologists are practising or have come across.
منابع مشابه
Therapeutic options in the treatment of benign prostatic hyperplasia
Current theraputic options for the treatment of symptomatic benign prostatic hyperplasia (BPH) are reviewed. Therapeutic options for mild lower urinary tract symptoms (LUTS), as defined by the American Urological Association, are generally treated medically. Moderate to severe LUTS can be treated medically or with surgical therapy. Current medical and surgical treatments for LUTS secondary to B...
متن کاملBenign prostatic hyperplasia.
This article reviews the epidemiology of benign prostatic hyperplasia (BPH), evaluation of patients with lower urinary tract symptomatology (LUTS), and management of patients with BPH and LUTS. The evaluation includes history and physical examination, laboratory testing, and specialized studies. The management includes medical and surgical options. Medical options include alpha-1-adrenergic rec...
متن کاملEvaluation of c-Myc mRNA Expression Level in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Tissues and Its Correlation with Clinicopathological Characteristics
Background and Aims: Prostate cancer (PCa) is one of the most common cancers among men in Iran. Since changes in the regulation of proto-oncogenes expression are the main causes of most human cancers, including PCa, evaluating the expression of marker genes can be helpful for early diagnosis of cancer and better understanding of its etiology. The present study compared c-Myc expression level in...
متن کاملI-56: Value of 3D XI (Computed UltrasoundTomography) in the Evaluation of Benign ProstaticHyperplasia and Preservation of Men Infertility
The prevalence and incidence of clinical problems secondary to and associated with benign prostatic hyperplasia (BPH) have been increasing as the population ages. Men with lower urinary tract obstruction (LUTS) may have sexual dysfunction, including ejaculatory loss, painful ejaculation, and sometimes erectile dysfunction (ED). Even though, the pathogenic relationship between BPH and these symp...
متن کاملBenign prostatic hyperplasia: now we can begin to tailor treatment.
Our treatment strategies for benign prostatic hyperplasia (BPH) have changed, with new insights into the pathophysiology of the disease, new clinical trials, and surgical advances. We present an update on treatment options and a diagnostic and treatment algorithm for this condition.
متن کاملComparison of Matrix Metalloproteinases 2 mRNA Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
Background and Aims: Prostate cancer is the second most common cancer in men worldwide in men. Matrix metalloproteinase 2 (MMP2) has a role in the invasion and destruction of the basement membrane and the extra-cellular matrix and facilitating the process of tumor cell invasion. The present study was conducted to compare the expression of MMP2 gene in prostate cancer (PCa) and benign prostatic ...
متن کامل